Steven R. Rousey

Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation

Steven R. Rousey, Susan Russler, Mark S. Gottlieb et al. · The American Journal of Medicine · 1991 · 137 citations

Life Sciences, Infectious Diseases, Microbiology +16

A multi-center phase II study of sequential paclitaxel and bryostatin-1 (NSC 339555) in patients with untreated, advanced gastric or gastroesophageal junction adenocarcinoma

Jaffer A. Ajani, Yixing Jiang, Josephine Faust et al. · Investigational New Drugs · 2006 · 66 citations

Medicine, Oncology, Surgery +13

Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer

Guru Sonpavde, Ana M. Aparicio, Feng Zhan et al. · Urologic Oncology Seminars and Original Investigations · 2009 · 63 citations

Medicine, Oncology, Pharmacology +16

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe et al. · Journal of Thoracic Oncology · 2010 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

Mark T. Fleming, Guru Sonpavde, Michael Kolodziej et al. · Clinical Genitourinary Cancer · 2012 · 32 citations

Medicine, Oncology, Pharmacology +14